West Pharmaceutical Services Inc (WST)
339.80
+3.97 (+1.18%)
USD |
NYSE |
Mar 28, 16:00
340.00
+0.20 (+0.06%)
After-Hours: 20:00
West Pharmaceutical Services Revenue (TTM): 2.887B for Dec. 31, 2022
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 2.887B |
| September 30, 2022 | 2.909B |
| June 30, 2022 | 2.929B |
| March 31, 2022 | 2.881B |
| December 31, 2021 | 2.832B |
| September 30, 2021 | 2.681B |
| June 30, 2021 | 2.522B |
| March 31, 2021 | 2.326B |
| December 31, 2020 | 2.147B |
| September 30, 2020 | 2.037B |
| June 30, 2020 | 1.945B |
| March 31, 2020 | 1.888B |
| December 31, 2019 | 1.840B |
| September 30, 2019 | 1.792B |
| June 30, 2019 | 1.767B |
| March 31, 2019 | 1.745B |
| December 31, 2018 | 1.717B |
| September 30, 2018 | 1.710B |
| June 30, 2018 | 1.677B |
| March 31, 2018 | 1.627B |
| December 31, 2017 | 1.599B |
| September 30, 2017 | 1.566B |
| June 30, 2017 | 1.544B |
| March 31, 2017 | 1.535B |
| December 31, 2016 | 1.509B |
| Date | Value |
|---|---|
| September 30, 2016 | 1.486B |
| June 30, 2016 | 1.454B |
| March 31, 2016 | 1.426B |
| December 31, 2015 | 1.400B |
| September 30, 2015 | 1.390B |
| June 30, 2015 | 1.401B |
| March 31, 2015 | 1.410B |
| December 31, 2014 | 1.421B |
| September 30, 2014 | 1.414B |
| June 30, 2014 | 1.400B |
| March 31, 2014 | 1.376B |
| December 31, 2013 | 1.368B |
| September 30, 2013 | 1.347B |
| June 30, 2013 | 1.309B |
| March 31, 2013 | 1.290B |
| December 31, 2012 | 1.266B |
| September 30, 2012 | 1.240B |
| June 30, 2012 | 1.230B |
| March 31, 2012 | 1.213B |
| December 31, 2011 | 1.192B |
| September 30, 2011 | 1.174B |
| June 30, 2011 | 1.152B |
| March 31, 2011 | 1.125B |
| December 31, 2010 | 1.105B |
| September 30, 2010 | 1.121B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.627B
Minimum
Mar 2018
2.929B
Maximum
Jun 2022
2.193B
Average
1.991B
Median
Revenue (TTM) Benchmarks
| ShockWave Medical Inc | 489.73M |
| Merit Medical Systems Inc | 1.151B |
| Integer Holdings Corp | 1.376B |
| Becton, Dickinson and Co | 19.00B |
| Perspective Therapeutics Inc | 8.967M |